Baseline demographic, clinical and imaging/neuropathological information across AD variants is presented in Table 1 (tau-PET cohort) and Table 2 (post-mortem cohort), while baseline demographic and clinical information across all sites can be found in Supplementary Table 1. The gene discussed is MAPT; the disease is Alzheimer disease.